Send to

Choose Destination
Pharmacol Rep. 2007 Jul-Aug;59(4):402-7.

Effect of valproate derivatives on human brain myo-inositol-1-phosphate (MIP) synthase activity and amphetamine-induced rearing.

Author information

Stanley Research Center, Ben-Gurion University of the Negev, PO Box 4600, Beersheva 84170, Israel.

Erratum in

  • Pharmacol Rep. 2008 Mar-Apr;60(2):292. Galit, Shaltiel [corrected to Shaltiel, Galit]; Shirley, Mark [corrected to Mark, Shirley]; Ora, Kofman [corrected to Kofman, Ora]; Galila, Agam [corrected to Agam, Galila].


We have recently shown that valproate (VPA) decreases intracellular concentrations of inositol, like lithium but via a different mechanism, namely by inhibiting myo-inositol-1-phosphate (MIP) synthase. Valnoctamide (VCD) and valrocemide (VGD) are VPA derivatives which are anticonvulsants and have been shown in animal models to be significantly less teratogenic than VPA. We now show that 1 mM of either VCD or VGD drastically inhibits human brain crude homogenate MIP synthase activity. We studied the mechanism of the effect of VCD and found that it reduced the enzyme activity by an apparent competitive mode of inhibition at concentrations within the therapeutic range of VPA(Ki = 0.18 mM). We studied the behavioral effect of VGD and found that both lithium and VGD attenuated amphetamine-induced increase in rearing. These data support clinical study of these VPA-derivatives in bipolar disorder.

[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Institute of Pharmacology Polish Academy of Sciences
Loading ...
Support Center